Treatment advances in liver-limited metastatic colorectal cancer

Steven Robert Alberts, Graeme J. Poston

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Over the last several decades advances in the management and treatment of patients with liver metastases from colorectal cancer (CRC) has changed a disease with a dismal prognosis to one with a potential for cure in some patients. Advances have been made through coordinated management of patients by surgeons, medical oncologists, radiologists, and other health care professionals coupled with advances in treatment options. Although these advances have clearly impacted patient outcomes, it is clear that the benefit of traditional surgical approaches and the use of cytoxic chemotherapy are reaching a plateau. Continued research to develop new and more active therapies, including targeted or biologic agents, is needed. This review discusses the advances made in management of patients with liver-limited metastatic disease.

Original languageEnglish (US)
Pages (from-to)258-265
Number of pages8
JournalClinical Colorectal Cancer
Volume10
Issue number4
DOIs
StatePublished - 2011

Fingerprint

Colorectal Neoplasms
Liver
Therapeutics
Biological Factors
Neoplasm Metastasis
Delivery of Health Care
Drug Therapy
Research

Keywords

  • Colorectal cancer
  • Liver metastases
  • Metachronous metastasis
  • Resectability
  • Synchronous metastasis

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Treatment advances in liver-limited metastatic colorectal cancer. / Alberts, Steven Robert; Poston, Graeme J.

In: Clinical Colorectal Cancer, Vol. 10, No. 4, 2011, p. 258-265.

Research output: Contribution to journalArticle

@article{a4a84293213646d980604bf570664d0f,
title = "Treatment advances in liver-limited metastatic colorectal cancer",
abstract = "Over the last several decades advances in the management and treatment of patients with liver metastases from colorectal cancer (CRC) has changed a disease with a dismal prognosis to one with a potential for cure in some patients. Advances have been made through coordinated management of patients by surgeons, medical oncologists, radiologists, and other health care professionals coupled with advances in treatment options. Although these advances have clearly impacted patient outcomes, it is clear that the benefit of traditional surgical approaches and the use of cytoxic chemotherapy are reaching a plateau. Continued research to develop new and more active therapies, including targeted or biologic agents, is needed. This review discusses the advances made in management of patients with liver-limited metastatic disease.",
keywords = "Colorectal cancer, Liver metastases, Metachronous metastasis, Resectability, Synchronous metastasis",
author = "Alberts, {Steven Robert} and Poston, {Graeme J.}",
year = "2011",
doi = "10.1016/j.clcc.2011.06.008",
language = "English (US)",
volume = "10",
pages = "258--265",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Treatment advances in liver-limited metastatic colorectal cancer

AU - Alberts, Steven Robert

AU - Poston, Graeme J.

PY - 2011

Y1 - 2011

N2 - Over the last several decades advances in the management and treatment of patients with liver metastases from colorectal cancer (CRC) has changed a disease with a dismal prognosis to one with a potential for cure in some patients. Advances have been made through coordinated management of patients by surgeons, medical oncologists, radiologists, and other health care professionals coupled with advances in treatment options. Although these advances have clearly impacted patient outcomes, it is clear that the benefit of traditional surgical approaches and the use of cytoxic chemotherapy are reaching a plateau. Continued research to develop new and more active therapies, including targeted or biologic agents, is needed. This review discusses the advances made in management of patients with liver-limited metastatic disease.

AB - Over the last several decades advances in the management and treatment of patients with liver metastases from colorectal cancer (CRC) has changed a disease with a dismal prognosis to one with a potential for cure in some patients. Advances have been made through coordinated management of patients by surgeons, medical oncologists, radiologists, and other health care professionals coupled with advances in treatment options. Although these advances have clearly impacted patient outcomes, it is clear that the benefit of traditional surgical approaches and the use of cytoxic chemotherapy are reaching a plateau. Continued research to develop new and more active therapies, including targeted or biologic agents, is needed. This review discusses the advances made in management of patients with liver-limited metastatic disease.

KW - Colorectal cancer

KW - Liver metastases

KW - Metachronous metastasis

KW - Resectability

KW - Synchronous metastasis

UR - http://www.scopus.com/inward/record.url?scp=84855945774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855945774&partnerID=8YFLogxK

U2 - 10.1016/j.clcc.2011.06.008

DO - 10.1016/j.clcc.2011.06.008

M3 - Article

VL - 10

SP - 258

EP - 265

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 4

ER -